Alta Vista hires Jacob Capital to complete RedeCan buy 2016-01-25 13:17 ET - News Release
Mr. Ian Foreman reports
ALTA VISTA ENGAGES JACOB CAPITAL MANAGEMENT INC.
Alta Vista Ventures Ltd. has signed an engagement letter with Jacob Capital Management Inc. for the purposes of completing the acquisition of RedeCan Pharm and expanding its operations. RedeCan Pharm is one of Canada's 20 marijuana for medical purposes regulations cultivation and sales licences (see news release dated Nov. 27, 2015).
"We are very familiar with RedeCan Pharm and the great job the founders have done in growing the business to its current level. In particular, the low-cost operating environment and the considerable acres available for expansion serve as a solid foundation to build on. We look forward to working with the RedeCan Pharm and Alta Vista teams to complete this compelling transaction and develop the underlying business into one of the leading producers in the MMPR program," stated Khurram Malik, cannabis lead at Jacob Capital Management.
"The JCMI team has been very active in the medical marijuana sector and was one of the first to realize the potential of the space. They will be a value-added partner in that they will be able to help us with many facets of building our business," stated Ian Foreman, president of Alta Vista.
In consideration for acting as strategic adviser, Alta Vista has issued JCMI 500,000 shares. An additional one million shares will be issued on March 6, 2016, and 2.5 million shares will be issued to JCMI upon the successful completion of the acquisition of RedeCan.
We seek Safe Harbor.